It has been reported that ABCF1 is overexpressed in liver cancer; is a liver tumor fetal protein that promotes chemotherapy resistance, epithelial-mesenchymal transition and tumor stem cell differentiation in liver cancer cells; and has potential as a therapeutic target. Here, ABCF1 is linked to neoplasm.